Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-14 - Early Changes in Plasma CXCL2 and MMP2 Levels Predicts the Response to Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Norikazu Matsuo | Author(s): Koichi Azuma, kenta Murotani, Hidenobu Ishii, Takaaki Tokito, Kazuhiko Yamada, Yuji Shibata, Tadasuke Shimokawaji, Yoshiro Nakahara, Tetsuro Kondo, Terufumi Kato, Haruhiro Saito, Kouzo Yamada, Tetsuro Sasada, Tomoaki Hoshino
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-30 - Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
09:45 - 09:45 | Presenter: Takaaki Tokito | Author(s): Ryo Ko, Chiyo K Imamura, Takehito Shukuya, Naoko Shimada, Ryo Koyama, Kazuhiko Yamada, Hidenobu Ishii, Koichi Azuma, Kazuhisa Takahashi
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-01 - Changes of BCR Repertoire Are Predictive Biomarker for the Efficacy of Immune Checkpoint Inhibitor in NSCLC
10:15 - 10:15 | Presenter: Koichi Azuma | Author(s): Yoshiro Nakahara, Norikazu Matsuo, Hidenobu Ishii, Takaaki Tokito, kenta Murotani, Tomoaki Hoshino, Tetsuro Sasada
- Abstract
Loading... -
+
P2.04-85 - Clinical Significance of the PD-L2 Expression in Patients with NSCLC Receiving Anti-PD-1 Inhibitors
10:15 - 10:15 | Presenter: Hidenobu Ishii | Author(s): Koichi Azuma, Norikazu Matsuo, Takaaki Tokito, Kazuhiko Yamada, Tomoaki Hoshino
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.11 - A Multicenter Phase II Study of Low-Dose Erlotinib in Frail Patients with EGFR Mutation-Positive, Non-Small Cell Lung Cancer: TORG1425
15:40 - 15:45 | Presenter: Sakiko Otani | Author(s): Kazuhiko Yamada, Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii, Akihiro Bessho, Shinobu Hosokawa, Hideo Kunitoh, Kazuhito Miyazaki, Hiroshi Tanaka, Satoru Miura, Hiromi Aono, Yoshiro Nakahara, Kei Kusaka, Yukio Hosomi, Akinobu Hamada, Hiroaki Okamoto
- Abstract
Loading...